secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001558370-23-019636
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Biosciences CFO McDavid Stilwell resigns effective Dec 31, 2023
-----------------------------------------------------------------------

- CFO McDavid Stilwell resigns to pursue other opportunities; effective Dec 31, 2023.
- Resignation not related to any disagreement with company's operations, financials, or policies.
- No successor named yet; Stilwell may provide transitional services by mutual agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023019636/0001558370-23-019636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023019636/chrs-20231207x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer